scholarly article | Q13442814 |
P356 | DOI | 10.1136/ARD.2010.142109 |
P698 | PubMed publication ID | 21097657 |
P50 | author | Lars Klareskog | Q5912759 |
Peter K. Gregersen | Q7175067 | ||
Tom Huizinga | Q77086497 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rheumatism | Q684924 |
P304 | page(s) | 2062-2066 | |
P577 | publication date | 2010-12-01 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Prevention of autoimmune rheumatic disease: state of the art and future perspectives | |
P478 | volume | 69 |
Q36633359 | Autoantibody profiling to follow evolution of lupus syndromes |
Q37492376 | Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis |
Q55279741 | Automated Processing and Evaluation of Anti-Nuclear Antibody Indirect Immunofluorescence Testing. |
Q37589108 | Can rheumatoid arthritis be prevented? |
Q92277378 | Characterization of T-Cell Receptor Repertoire in Patients with Rheumatoid Arthritis Receiving Biologic Therapies |
Q92185716 | Cigarette smoke-induced reduction of C1q promotes emphysema |
Q36633164 | Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis |
Q42592977 | Developing better biomarkers for connective tissue disease-associated interstitial lung disease: citrullinated hsp90 autoantibodies in rheumatoid arthritis |
Q38145001 | Epigenetics in rheumatoid arthritis: a primer for rheumatologists |
Q39190505 | Epigenetics in the pathogenesis of RA. |
Q42375845 | Factors associated with the risk of gingival disease in patients with rheumatoid arthritis |
Q35533807 | Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis |
Q47563245 | Genetic and environmental risk factors for rheumatoid arthritis |
Q38554722 | Human autoimmune diseases: a comprehensive update |
Q38133018 | Immunopathogenic mechanisms of systemic autoimmune disease |
Q51092697 | Interplay between genetic and epigenetic mechanisms in rheumatoid arthritis. |
Q89523051 | Is the prevention of rheumatoid arthritis possible? |
Q89808044 | Measuring ACPA in the general population or primary care: is it useful? |
Q27003201 | Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE |
Q64994712 | Periodontal Health and Oral Microbiota in Patients with Rheumatoid Arthritis. |
Q33806701 | Pre-rheumatoid arthritis and its prevention |
Q26863306 | Preclinical lupus |
Q27000666 | Preclinical systemic lupus erythematosus |
Q38851096 | Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care |
Q38893197 | Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences |
Q37274455 | Regional differences regarding risk of developing rheumatoid arthritis in Stockholm County, Sweden: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study |
Q55970262 | Sjögren syndrome |
Q38169801 | Smoking and inflammation: evidence for a synergistic role in chronic disease |
Q36245865 | Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA). |
Q43194836 | Targeting mechanisms at sites of complement activation for imaging and therapy |
Q35747705 | The lung may play a role in the pathogenesis of rheumatoid arthritis |
Q50755235 | The presence of FCGR2B promoter or transmembrane region variant alleles leads to reduced serum IL-6 levels in rheumatoid arthritis. |
Q40369679 | The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis |
Q38024758 | Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis |
Q30587275 | Weighing in on autoimmune disease: Big data tip the scale. |
Q87824606 | [Synovial fibroblasts : Main players in rheumatoid arthritis] |
Search more.